Urothelial Cancer

• CLINICAL_TRIALS trial_result · 2014-09-25
  Clinical Trial Update: A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer [Phase 2]

  A Phase 2 trial of trastuzumab (Herceptin) as monotherapy for metastatic urothelial cancer was terminated, with results posted.

• CLINICAL_TRIALS trial_result · 2014-09-18
  Clinical Trial Update: Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) [Phase 2]

  A Phase 2 neoadjuvant chemotherapy trial in upper tract urothelial carcinoma (and bladder cancer) was terminated, with results posted in 201…

• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer [Phase 1]

  A Phase 1 trial of veliparib with cisplatin and gemcitabine in advanced biliary tract, pancreatic, urothelial, and non-small cell lung cance…

• CLINICAL_TRIALS trial_result · 2013-05-03
  Clinical Trial Update: Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]

  Phase 2 trial evaluating trastuzumab for previously treated, locally advanced or metastatic urothelial cancer was terminated.

• CLINICAL_TRIALS trial_result · 2013-03-21
  Clinical Trial Update: Pazopanib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]

  A Phase 2 trial of pazopanib in metastatic urothelial cancer has completed and results have been posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-06-17
  Clinical Trial Update: Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable) [Phase 1, Phase 2]

  This Phase 1/2 clinical trial evaluated bi-weekly pemetrexed plus cisplatin in patients with urothelial cancer (metastatic, locally advanced…